MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
433.07
-20.67
-4.56%
After Hours: 434.59 +1.52 +0.35% 16:47 03/27 EDT
OPEN
450.95
PREV CLOSE
453.74
HIGH
452.00
LOW
431.01
VOLUME
1.92M
TURNOVER
--
52 WEEK HIGH
513.98
52 WEEK LOW
362.50
MARKET CAP
110.01B
P/E (TTM)
28.26
1D
5D
1M
3M
1Y
5Y
1D
Watching Vertex Pharmaceuticals; Shares Trading Lower, FDA Label Update For ALYFTREK Adds Neuropsychiatric Risk Warning And Intracranial Hypertension, Alongside Strengthened Liver Safety Monitoring
Benzinga · 3h ago
Vertex’s VX-407 Kidney Study Completion: What Phase 1 Progress Means For VRTX Investors
TipRanks · 4h ago
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
Barchart · 17h ago
Maze Therapeutics Adds Pressure To Vertex In APOL1 Kidney Disease Race
Simply Wall St · 1d ago
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Vertex Pharmaceuticals (VRTX) and Sarepta Therapeutics (SRPT)
TipRanks · 1d ago
Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX), Pacira Pharmaceuticals (PCRX) and Alnylam Pharma (ALNY)
TipRanks · 1d ago
Where Will Vertex Pharmaceuticals Be in 1 Year?
The Motley Fool · 2d ago
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
TipRanks · 2d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.